LiveOnNY Hosts Largest Painted Legacy Event to Honor Donor Heroes in the Bronx

Painted Legacy brings together donor families, recipients, and advocates to transform photos of loved ones into…

Sustainability in Action: MemorialCare Honored with ASHE’s 2025 Energy to Care & Sustained Performance Awards Second Year in a Row

FOUNTAIN VALLEY, Calif., Dec. 12, 2025 /PRNewswire/ –MemorialCare, a leading health care provider in Southern California,…

ISHI Health Launches Virtual Heart Failure Clinics in California and Arizona

SAN DIEGO, Dec. 12, 2025 /PRNewswire/ — ISHI Health, an innovator in AI-enabled virtual cardiac care,…

IM Cannabis Appoints Asi Levi as Chief Financial Officer

TORONTO and GLIL YAM, Israel, Dec. 12, 2025 /PRNewswire/ — IM Cannabis Corp. (“IMC” or the…

Convoy of Hope Again Named to Forbes’ 2025 List of America’s Top Charities

Humanitarian Organization Ranked on Distinguished List for the Seventh Year in a Row SPRINGFIELD, Mo., Dec.…

CVS Health Updates Financial Guidance, Highlights Strength of Businesses, and Announces Strategy to Uniquely Reimagine Health Care at Investor Day Event

Outlines strategy to deliver best-in-class execution, transform consumer experiences, be the partner of choice, and harness…

Bio-Techne Launches the Enhanced Leo™ System Delivering Advanced Multiplexing and High-Throughput Protein Analysis

Combines chemiluminescence detection with dual-channel fluorescence in the near-infrared and infrared (NIR and IR) ranges for…

Cypherpunk Taps Zcash Founder Zooko as Strategic Advisor

CAMBRIDGE, Mass., Dec. 9, 2025 /PRNewswire/ –Cypherpunk Technologies Inc. (Nasdaq: CYPH) today announced that industry pioneer…

Bessemer Investors Invests in Xanitos

Partnership with Healthcare Cleaning Specialist Establishes New Platform for Bessemer NEW YORK, Dec. 9, 2025 /PRNewswire/…

Johnson & Johnson’s INLEXZO™ (gemcitabine intravesical system) delivers 74 percent disease-free survival at one year in BCG-unresponsive, high-risk, papillary-only NMIBC

New data from Cohort 4 of the SunRISe-1 study show more than 95 percent of patients…